1. Analiza tveganja uvedbe detajlističnih ambulant v SlovenijiMaja Trošt, 2008, undergraduate thesis Keywords: Slovenija, zdravstvo, zdravstveno varstvo, zavarovanje, podjetje, nakupovalni centri, tržna analiza, planiranje, kadri, konkurenca, analiza
Full text (outside link) |
2. Analiza napovednih indikatorjev slovenskega bruto domačega proizvodaMaja Trošt, 2011, master's thesis Keywords: Slovenija, gospodarska gibanja, ekonomski razvoj, ekonomska rast, bruto domači proizvod, ekonomska predvidevanja, indikatorji, časovne vrste, modeli
Full text (outside link) |
3. Serotonin-related functional genetic variants affect the occurrence of psychiatric and motor adverse events of dopaminergic treatment in Parkinson’s diseaseSara Redenšek, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, original scientific article Keywords: Parkinson’s disease, motor complications, visual hallucinations, impulse control disorders, dyskinesia, polymorphism, serotonin, adverse event, pharmacogenomics
Full text (file, 550,02 KB) This document has more files! More... |
4. Switching and combining device-aided therapies in advanced Parkinson’s diseaseDejan Georgiev, Sentilija Delalić, Nina Zupančič-Križnar, Achinoam Socher, Tanya Gurevich, Maja Trošt, 2022, original scientific article Keywords: advanced Parkinson’s disease, deep brain stimulation of the subthalamic nucleus, L-dopa/carbidopa intestinal gel infusion, continuous subcutaneous apomorphine infusion
Full text (file, 1020,95 KB) This document has more files! More... |
5. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's diseaseSara Redenšek, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, original scientific article Keywords: Parkinson's disease, susceptibility, polymorphism, inflammation, oxidative stress, adverse events
Full text (file, 673,75 KB) This document has more files! More... |
6. Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's diseaseSara Redenšek, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, original scientific article Keywords: Parkinson's disease, genetic polymorphism, dopaminergic pathway, personalized medicine, adverse events
Full text (file, 411,70 KB) This document has more files! More... |
|
8. Adverse effects of levodopa/carbidopa intrajejunal gel treatmentTomaž Rus, Maša Premzl, Nina Zupančič-Križnar, Milica Gregorič Kramberger, Robert Rajnar, Lidija Ocepek, Zvezdan Pirtošek, Maja Trošt, 2022, original scientific article Keywords: advanced Parkinson's disease, levodopa-carbidopa intestinal gel, percutaneous endoscopic gastrojejunostomy, adverse effects, health-related quality of life
Full text (file, 1,14 MB) This document has more files! More... |
9. Assessment of the telomere length and its effect on the symptomatology of Parkinson's diseaseTina Levstek, Sara Redenšek, Maja Trošt, Vita Dolžan, Katarina Trebušak Podkrajšek, 2021, original scientific article Keywords: Parkinson's disease, telomere length, levodopa treatment, telomere attrition, dementia
Full text (file, 737,20 KB) This document has more files! More... |
10. Metabolic brain pattern in dementia with Lewy bodiesMatej Perovnik, Petra Tomše, Jan Jamšek, Chris Chengke Tang, David Eidelberg, Maja Trošt, 2022, original scientific article Keywords: dementia with Lewy bodies, Alzheimer’s disease, biomarker, metabolic brain imaging, FDG PET, network analysis, scaled subprofile model/principal component analysis, SSM/PCA
Full text (file, 2,27 MB) This document has more files! More... |
